» Articles » PMID: 7737129

ATF-2 Contains a Phosphorylation-dependent Transcriptional Activation Domain

Overview
Journal EMBO J
Date 1995 Apr 18
PMID 7737129
Citations 167
Authors
Affiliations
Soon will be listed here.
Abstract

The ATF-2 transcription factor can mediate adenovirus E1A-inducible transcriptional activation. Deletion analysis has indicated that the N-terminal region of ATF-2 is essential for this response. Furthermore, the N-terminus can activate transcription in the absence of E1A when fused to a heterologous DNA binding domain. However, in the intact protein this activation domain is masked. In this report we show that residues in the N-terminus required for activation are also required for mediating E1A stimulation. In particular two threonine residues at positions 69 and 71 are essential. These residues are phosphorylated in vivo and can be efficiently phosphorylated in vitro by the JNK/SAPK subgroup of the MAPK family. ATF-2 can bind to a UV-inducible kinase through a region in the N-terminus that is distinct from the sites of phosphorylation; this binding region is both necessary for phosphorylation by JNK/SAPK in vitro and for transcriptional activation in vivo. The activity of the N-terminus is stimulated by UV irradiation which stimulates the signalling pathway leading to JNK/SAPK. Finally, although ATF-2 binds to the E1A protein, the N-terminal activation domain is not required for this interaction. The results show that ATF-2, like other members of the ATF/CREB family of DNA binding proteins is regulated by specific signalling pathways.

Citing Articles

Current insight on the mechanisms of programmed cell death in sepsis-induced myocardial dysfunction.

Liu A, Li S, Yu Y, Zhang J, Ma L Front Cell Dev Biol. 2024; 11:1309719.

PMID: 38161332 PMC: 10754983. DOI: 10.3389/fcell.2023.1309719.


p38 Mitogen-Activated Protein Kinase Inhibition of Mesenchymal Transdifferentiated Tumor Cells in Head and Neck Squamous Cell Carcinoma.

Federspiel J, Greier M, Ladanyi A, Dudas J Biomedicines. 2023; 11(12).

PMID: 38137525 PMC: 10741606. DOI: 10.3390/biomedicines11123301.


Emerging roles of activating transcription factor 2 in the development of breast cancer: a comprehensive review.

Amarah A, Elsabagh A, Ouda A, Karen O, Ferih K, Elmakaty I Precis Clin Med. 2023; 6(4):pbad028.

PMID: 37955015 PMC: 10639104. DOI: 10.1093/pcmedi/pbad028.


PcEiger links the Imd/Relish pathway to ROS production in the intestine of the red swamp crayfish.

Wang H, Liu P, Wei Z, Wang X EMBO Rep. 2023; 24(5):e55903.

PMID: 36975049 PMC: 10157377. DOI: 10.15252/embr.202255903.


Investigation of the anti-tumor mechanism of tirabrutinib, a highly selective Bruton's tyrosine kinase inhibitor, by phosphoproteomics and transcriptomics.

Kozaki R, Yasuhiro T, Kato H, Murai J, Hotta S, Ariza Y PLoS One. 2023; 18(3):e0282166.

PMID: 36897912 PMC: 10004634. DOI: 10.1371/journal.pone.0282166.


References
1.
Smeal T, Binetruy B, Mercola D, Heidecker G, Rapp U, Karin M . Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73. Mol Cell Biol. 1992; 12(8):3507-13. PMC: 364600. DOI: 10.1128/mcb.12.8.3507-3513.1992. View

2.
Hill C, Marais R, John S, Wynne J, Dalton S, Treisman R . Functional analysis of a growth factor-responsive transcription factor complex. Cell. 1993; 73(2):395-406. DOI: 10.1016/0092-8674(93)90238-l. View

3.
Muegge K, Vila M, Gusella G, Musso T, Herrlich P, Stein B . Interleukin 1 induction of the c-jun promoter. Proc Natl Acad Sci U S A. 1993; 90(15):7054-8. PMC: 47074. DOI: 10.1073/pnas.90.15.7054. View

4.
Patel G, Nasmyth K, Jones N . A new method for the isolation of recombinant baculovirus. Nucleic Acids Res. 1992; 20(1):97-104. PMC: 310331. DOI: 10.1093/nar/20.1.97. View

5.
Lee C, Yun Y, Hoeffler J, Habener J . Cyclic-AMP-responsive transcriptional activation of CREB-327 involves interdependent phosphorylated subdomains. EMBO J. 1990; 9(13):4455-65. PMC: 552238. DOI: 10.1002/j.1460-2075.1990.tb07896.x. View